Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Nasopharyngeal Surfactant Administration to Prevent Neonatal Respiratory Distress Syndrome

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kattwinkel J, Robinson M, Bloom BT, Delmore P, Ferguson JE . Technique for intrapartum administration of surfactant without requirement for an endotracheal tube. J Perinatol 2004;24(6):360–365.

    Article  CAS  Google Scholar 

  2. Enhorning G, Grossmann G, Robertson B . Pharyngeal deposition of surfactant in the premature rabbit fetus. Biol Neonate 1973;22(1):126–132.

    Article  CAS  Google Scholar 

  3. Enhorning G, Robertson B, Milne E, Wagner R . Radiologic evaluation of the premature newborn rabbit after pharyngeal deposition of surfactant. Am J Obstet Gynecol 1975;121(4):475–480.

    Article  CAS  Google Scholar 

  4. Hirschl RB . Current experience with liquid ventilation. Paediatr Respir Rev 2004;5(Suppl A):S339–S345.

    Article  Google Scholar 

  5. Leach CL, Greenspan JS, Rubenstein SD, et al. Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome. The LiquiVent Study Group. N Engl J Med 1996;335(11):761–767.

    Article  CAS  Google Scholar 

  6. von der Hardt K, Schoof E, Kandler MA, Dotsch J, Rascher W . Aerosolized perfluorocarbon suppresses early pulmonary inflammatory response in a surfactant-depleted piglet model. Pediatr Res 2002;51(2):177–182.

    Article  CAS  Google Scholar 

  7. von der Hardt K, Kandler MA, Brenn G, et al. Comparison of aerosol therapy with different perfluorocarbons in surfactant-depleted animals. Crit Care Med 2004;32(5):1200–1206.

    Article  CAS  Google Scholar 

  8. Horbar JD, Carpenter JH, Buzas J, et al., for the members of the Vermont Oxford Network. Timing of initial surfactant treatment for infants 23 to 29 weeks’ gestation: is routine practice evidence based? Pediatrics 2004;113(6):1593–1602.

    Article  Google Scholar 

  9. Soll RF, Morley CJ . Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2001; (2):CD000510.

  10. Dunn MS, Reilly MC . Approaches to the initial respiratory management of preterm neonates. Paediatr Respir Rev 2003;4(1):2–8.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fernandes, C., Horst, D. & O'Donovan, D. Nasopharyngeal Surfactant Administration to Prevent Neonatal Respiratory Distress Syndrome. J Perinatol 25, 361–362 (2005). https://doi.org/10.1038/sj.jp.7211264

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7211264

Search

Quick links